Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Payables: 2020-2023

Historic Payables for Therapeutics (RAPT) over the last 4 years, with Dec 2023 value amounting to $5.2 million.

  • Therapeutics' Payables fell 73.95% to $1.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $16.0 million, marking a year-over-year decrease of 20.94%. This contributed to the annual value of $5.2 million for FY2023, which is 53.82% up from last year.
  • According to the latest figures from FY2023, Therapeutics' Payables is $5.2 million, which was up 53.82% from $3.4 million recorded in FY2022.
  • Therapeutics' Payables' 5-year high stood at $5.2 million during FY2023, with a 5-year trough of $2.0 million in FY2021.
  • Over the past 3 years, Therapeutics' median Payables value was $3.4 million (recorded in 2022), while the average stood at $3.5 million.
  • Its Payables has fluctuated over the past 5 years, first dropped by 16.11% in 2021, then spiked by 68.33% in 2022.
  • Therapeutics' Payables (Yearly) stood at $2.4 million in 2020, then declined by 16.11% to $2.0 million in 2021, then skyrocketed by 68.33% to $3.4 million in 2022, then soared by 53.82% to $5.2 million in 2023.